Ruizal, Nancy C.
HRN: 21-47-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2022
CEFUROXIME 1.5GM (VIAL)
06/23/2022
06/29/2022
IV
1.5 G
Q8
T/c Sepsis Sec To Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes